These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 22653914)

  • 1. Rugulactone and its analogues exert antibacterial effects through multiple mechanisms including inhibition of thiamine biosynthesis.
    Nodwell MB; Menz H; Kirsch SF; Sieber SA
    Chembiochem; 2012 Jul; 13(10):1439-46. PubMed ID: 22653914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective synthesis and biological evaluation of (R)-rugulactone, (6R)-((4R)-hydroxy-6-phenyl-hex-2-enyl)-5,6-dihydro-pyran-2-one and its 4S epimer.
    Reddy DK; Shekhar V; Prabhakar P; Chinna Babu B; Siddhardha B; Murthy US; Venkateswarlu Y
    Eur J Med Chem; 2010 Oct; 45(10):4657-63. PubMed ID: 20705370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa.
    Meragelman TL; Scudiero DA; Davis RE; Staudt LM; McCloud TG; Cardellina JH; Shoemaker RH
    J Nat Prod; 2009 Mar; 72(3):336-9. PubMed ID: 19093800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structurally refined beta-lactones as potent inhibitors of devastating bacterial virulence factors.
    Böttcher T; Sieber SA
    Chembiochem; 2009 Mar; 10(4):663-6. PubMed ID: 19206121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of primycin against multiple strains of gram-positive bacteria.
    Uri JV
    Acta Microbiol Hung; 1986; 33(2):141-6. PubMed ID: 3101392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase.
    Lira R; Xiang AX; Doundoulakis T; Biller WT; Agrios KA; Simonsen KB; Webber SE; Sisson W; Aust RM; Shah AM; Showalter RE; Banh VN; Steffy KR; Appleman JR
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6797-800. PubMed ID: 17980587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Target profiling of 4-hydroxyderricin in S. aureus reveals seryl-tRNA synthetase binding and inhibition by covalent modification.
    Battenberg OA; Yang Y; Verhelst SH; Sieber SA
    Mol Biosyst; 2013 Mar; 9(3):343-51. PubMed ID: 23295910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of improved β-lactone-based anti-virulence drugs targeting ClpP.
    Zeiler E; Korotkov VS; Lorenz-Baath K; Böttcher T; Sieber SA
    Bioorg Med Chem; 2012 Jan; 20(2):583-91. PubMed ID: 21855356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages.
    Seral C; Barcia-Macay M; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Efficient Chemoenzymatic Approach towards the Synthesis of Rugulactone.
    Tyrikos-Ergas T; Giannopoulos V; Smonou I
    Molecules; 2018 Mar; 23(3):. PubMed ID: 29534553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of finafloxacin, a novel fluoroquinolone with increased activity at acid pH, towards extracellular and intracellular Staphylococcus aureus, Listeria monocytogenes and Legionella pneumophila.
    Lemaire S; Van Bambeke F; Tulkens PM
    Int J Antimicrob Agents; 2011 Jul; 38(1):52-9. PubMed ID: 21596526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
    Angehrn P; Buchmann S; Funk C; Goetschi E; Gmuender H; Hebeisen P; Kostrewa D; Link H; Luebbers T; Masciadri R; Nielsen J; Reindl P; Ricklin F; Schmitt-Hoffmann A; Theil FP
    J Med Chem; 2004 Mar; 47(6):1487-513. PubMed ID: 14998336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5,6-Dihydro-α-pyrones from the leaves of Cryptocarya pulchinervia (Lauraceae).
    Juliawaty LD; Ra'idah PN; Abdurrahman S; Hermawati E; Alni A; Tan MI; Ishikawa H; Syah YM
    J Nat Med; 2020 Jun; 74(3):584-590. PubMed ID: 32207026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Aminotetralones: novel inhibitors of MurA and MurZ.
    Dunsmore CJ; Miller K; Blake KL; Patching SG; Henderson PJ; Garnett JA; Stubbings WJ; Phillips SE; Palestrant DJ; Angeles Jde L; Leeds JA; Chopra I; Fishwick CW
    Bioorg Med Chem Lett; 2008 Mar; 18(5):1730-4. PubMed ID: 18261901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenylimidazole derivatives of 4-pyridone as dual inhibitors of bacterial enoyl-acyl carrier protein reductases FabI and FabK.
    Kitagawa H; Ozawa T; Takahata S; Iida M; Saito J; Yamada M
    J Med Chem; 2007 Sep; 50(19):4710-20. PubMed ID: 17713898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin B1 de novo synthesis in the human malaria parasite Plasmodium falciparum depends on external provision of 4-amino-5-hydroxymethyl-2-methylpyrimidine.
    Wrenger C; Eschbach ML; Müller IB; Laun NP; Begley TP; Walter RD
    Biol Chem; 2006 Jan; 387(1):41-51. PubMed ID: 16497163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory activities of lichen-derived compounds against methicillin- and multidrug-resistant Staphylococcus aureus.
    Kokubun T; Shiu WK; Gibbons S
    Planta Med; 2007 Feb; 73(2):176-9. PubMed ID: 17415880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myxopyronin B analogs as inhibitors of RNA polymerase, synthesis and biological evaluation.
    Doundoulakis T; Xiang AX; Lira R; Agrios KA; Webber SE; Sisson W; Aust RM; Shah AM; Showalter RE; Appleman JR; Simonsen KB
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5667-72. PubMed ID: 15482944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrasting effects of human THP-1 cell differentiation on levofloxacin and moxifloxacin intracellular accumulation and activity against Staphylococcus aureus and Listeria monocytogenes.
    Van de Velde S; Nguyen HA; Van Bambeke F; Tulkens PM; Grellet J; Dubois V; Quentin C; Saux MC
    J Antimicrob Chemother; 2008 Sep; 62(3):518-21. PubMed ID: 18544595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzae.
    Lerner CG; Hajduk PJ; Wagner R; Wagenaar FL; Woodall C; Gu YG; Searle XB; Florjancic AS; Zhang T; Clark RF; Cooper CS; Mack JC; Yu L; Cai M; Betz SF; Chovan LE; McCall JO; Black-Schaefer CL; Kakavas SJ; Schurdak ME; Comess KM; Walter KA; Edalji R; Dorwin SA; Smith RA; Hebert EJ; Harlan JE; Metzger RE; Merta PJ; Baranowski JL; Coen ML; Thornewell SJ; Shivakumar AG; Saiki AY; Soni N; Bui M; Balli DJ; Sanders WJ; Nilius AM; Holzman TF; Fesik SW; Beutel BA
    Chem Biol Drug Des; 2007 Jun; 69(6):395-404. PubMed ID: 17581233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.